3 Investing Facts About Required Minimum Distributions You Need to Know - December 20, 2019Zacks Investment Research • 12/20/19
The Biggest Biotech Just Touched A Record High — Is Amgen Stock A Buy?Investors Business Daily • 12/05/19
Why Novartis's $9.7 Billion Purchase of The Medicines Company Is Bad News for AmgenThe Motley Fool • 12/02/19
Amgen (AMGN) Up 11.2% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 11/28/19
Healthy New Drug Sales And A Refreshed Pipeline Helping Lundbeck Set A BottomSeeking Alpha • 11/26/19